63 related articles for article (PubMed ID: 21414800)
1. Methodological remarks on the recent meta-analysis examining the association between glutathione-S-transferase M1 polymorphism and sporadic colorectal cancer risk.
Sergentanis TN; Economopoulos KP
Ann Epidemiol; 2011 Sep; 21(9):717-8. PubMed ID: 21414800
[No Abstract] [Full Text] [Related]
2. Glutathione S-transferase M1 polymorphism and sporadic colorectal cancer risk: An updating meta-analysis and HuGE review of 36 case-control studies.
Gao Y; Cao Y; Tan A; Liao C; Mo Z; Gao F
Ann Epidemiol; 2010 Feb; 20(2):108-21. PubMed ID: 20123161
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphism of glutathione S-transferase T1 and the risk of colorectal cancer: a meta-analysis.
Wan H; Zhou Y; Yang P; Chen B; Jia G; Wu X
Cancer Epidemiol; 2010 Feb; 34(1):66-72. PubMed ID: 20061204
[TBL] [Abstract][Full Text] [Related]
4. Association between glutathione S-transferase T1, M1, and P1 genotypes and the risk of colorectal cancer.
Cong N; Liu L; Xie Y; Shao W; Song J
J Korean Med Sci; 2014 Nov; 29(11):1488-92. PubMed ID: 25408579
[TBL] [Abstract][Full Text] [Related]
5. Glutathione S-transferase GSTM1 and GSTT1 polymorphisms and colorectal cancer risk: a prospective study.
Gertig DM; Stampfer M; Haiman C; Hennekens CH; Kelsey K; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1001-5. PubMed ID: 9829708
[TBL] [Abstract][Full Text] [Related]
6. Glutathione S-transferase M1 null genotype related to poor prognosis of colorectal cancer.
Yan S; Wang Z; Wang Z; Duan Q; Wang X; Li J; Sun B
Tumour Biol; 2016 Aug; 37(8):10229-34. PubMed ID: 26831664
[TBL] [Abstract][Full Text] [Related]
7. A meta-analysis of 20 case-control studies of the glutathione S-transferase M1 (GSTM1) status and colorectal cancer risk.
Ye Z; Parry JM
Med Sci Monit; 2003 Oct; 9(10):SR83-91. PubMed ID: 14523342
[TBL] [Abstract][Full Text] [Related]
8. Glutathione S-transferase (GSTM1 and GSTT1)-dependent risk for colorectal cancer.
Laso N; Lafuente MJ; Mas S; Trias M; Ascaso C; Molina R; Ballesta A; Rodriguez F; Lafuente A
Anticancer Res; 2002; 22(6A):3399-403. PubMed ID: 12530094
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphism of conjugating enzymes and cancer risk: GSTM1, GSTT1, NAT1 and NAT2.
Lee E; Huang Y; Zhao B; Seow-Choen F; Balakrishnan A; Chan SH
J Toxicol Sci; 1998 Jul; 23 Suppl 2():140-2. PubMed ID: 9760451
[No Abstract] [Full Text] [Related]
10. Polymorphisms of glutathione-S-transferase and arylamine N-acetyltransferase enzymes and susceptibility to colorectal cancer.
Kiss I; Németh A; Bogner B; Pajkos G; Orsós Z; Sándor J; Csejtey A; Faluhelyi Z; Rodler I; Ember I
Anticancer Res; 2004; 24(6):3965-70. PubMed ID: 15736440
[TBL] [Abstract][Full Text] [Related]
11. Human glutathione S-transferase P1 polymorphism and susceptibility to smoking related epithelial cancer; oral, lung, gastric, colorectal and urothelial cancer.
Katoh T; Kaneko S; Takasawa S; Nagata N; Inatomi H; Ikemura K; Itoh H; Matsumoto T; Kawamoto T; Bell DA
Pharmacogenetics; 1999 Apr; 9(2):165-9. PubMed ID: 10376763
[TBL] [Abstract][Full Text] [Related]
12. GSTP1 and GSTA1 polymorphisms interact with cruciferous vegetable intake in colorectal adenoma risk.
Tijhuis MJ; Wark PA; Aarts JM; Visker MH; Nagengast FM; Kok FJ; Kampman E
Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2943-51. PubMed ID: 16365014
[TBL] [Abstract][Full Text] [Related]
13. Glutathione S-transferases mu 1, theta 1, pi 1, alpha 1 and mu 3 genetic polymorphisms and the risk of colorectal and gastric cancers in humans.
Martínez C; Martín F; Fernández JM; García-Martín E; Sastre J; Díaz-Rubio M; Agúndez JA; Ladero JM
Pharmacogenomics; 2006 Jul; 7(5):711-8. PubMed ID: 16886896
[TBL] [Abstract][Full Text] [Related]
14. Human genome epidemiologic reviews: the beginning of something HuGE.
Khoury MJ; Little J
Am J Epidemiol; 2000 Jan; 151(1):2-3. PubMed ID: 10625169
[No Abstract] [Full Text] [Related]
15. Glutathione S-transferase activity and glutathione S-transferase mu expression in subjects with risk for colorectal cancer.
Szarka CE; Pfeiffer GR; Hum ST; Everley LC; Balshem AM; Moore DF; Litwin S; Goosenberg EB; Frucht H; Engstrom PF
Cancer Res; 1995 Jul; 55(13):2789-93. PubMed ID: 7796404
[TBL] [Abstract][Full Text] [Related]
16. GSTM1-null genotype as a risk factor for sporadic colorectal cancer in a Romanian population. Association with the NAT2-rapid-acetylator phenotype and exposure to environmental factors.
Procopciuc LM; Osian G
Cancer Invest; 2014 Feb; 32(2):53-62. PubMed ID: 24467372
[TBL] [Abstract][Full Text] [Related]
17. [The relationship between GSTM1, GSTT1 gene polymorphisms and susceptibility to sporadic colorectal adenocarcinoma].
Zhu Y; Deng C; Zhang Y; Zhou X; He X
Zhonghua Nei Ke Za Zhi; 2002 Aug; 41(8):538-40. PubMed ID: 12421502
[TBL] [Abstract][Full Text] [Related]
18. Glutathione S-transferase mu gene variants and colorectal cancer development--use of sequence-specific probes for an Iranian population.
Aghajany-Nasab M; Panjehpour M; Samiee SM; Rahimi F; Movahedian A
Asian Pac J Cancer Prev; 2011; 12(6):1511-5. PubMed ID: 22126490
[TBL] [Abstract][Full Text] [Related]
19. Glutathione S-transferase T1 gene polymorphism and colorectal cancer risk: an updated analysis.
Qin XP; Zhou Y; Chen Y; Li NN; Chen B; Yang P; Wu XT
Clin Res Hepatol Gastroenterol; 2013 Dec; 37(6):626-35. PubMed ID: 23773486
[TBL] [Abstract][Full Text] [Related]
20. Polymorphism of GSTM1 gene in patients with colorectal cancer and colonic polyps.
Gawrońska-Szklarz B; Lubiński J; Kladny J; Kurzawski G; Bielicki D; Wójcicki M; Sych Z; Musial HD
Exp Toxicol Pathol; 1999 Jul; 51(4-5):321-5. PubMed ID: 10445390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
